Genome-wide host responses against infectious laryngotracheitis virus vaccine infection in chicken embryo lung cells

BMC Genomics

Volumn 13, Issue 1, 2012, Pages

  Lee, Jeongyoon ^a,b   Bottje, Walter G ^a,b   Kong, Byung Whi ^a,b  

^a Department of Poultry Science   (United States)

^b UNIVERSITY OF ARKANSAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AQUAPORIN 5; BONE MORPHOGENETIC PROTEIN 2; CHOLECYSTOKININ; DOUBLE STRANDED DNA; FOLLISTATIN; LARYNGOTRACHEITIS VACCINE; MITOGEN ACTIVATED PROTEIN KINASE P38; NEUROMEDIN U; NUCLEAR FACTOR Y; PEPTIDYLPROLYL ISOMERASE; SERINE PROTEINASE INHIBITOR; THROMBOSPONDIN 2; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN RECEPTOR; VIRUS VACCINE; LIVE VACCINE;

ANIMAL CELL; ARTICLE; AVIAN INFECTIOUS LARYNGOTRACHEITIS; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; EMBRYO; GENE EXPRESSION; GENE MAPPING; GENETIC ASSOCIATION; GENETIC TRANSCRIPTION; HYBRIDIZATION; ILTOVIRUS; IMMUNE RESPONSE; INFLAMMATION; LUNG ALVEOLUS CELL; MICROARRAY ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; TISSUE CULTURE; VIRUS STRAIN; VIRUS VIRULENCE; ANIMAL; CHICK EMBRYO; CYTOLOGY; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORK; GENETICS; GENOMICS; HOST PATHOGEN INTERACTION; IMMUNOLOGY; LUNG; TIME; VIROLOGY;

GALLID HERPESVIRUS 1; GALLUS GALLUS;

ANIMALS; CHICK EMBRYO; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORKS; GENOMICS; HERPESVIRUS 1, GALLID; HOST-PATHOGEN INTERACTIONS; LUNG; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TIME FACTORS; VACCINES, ATTENUATED; VIRAL VACCINES;

EID: 84859935388     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-13-143     Document Type: Article

References (87)

1. Fuchs W, Veits J, Helferich D, Granzow H, Teifke JP, Mettenleiter TC. Molecular biology of avian infectious laryngotracheitis virus. Vet Res 2007, 38(2):261-279.
2. Lee SW, Markham PF, Markham JF, Petermann I, Noormohammadi AH, Browning GF, Ficorilli NP, Hartley CA, Devlin JM. First complete genome sequence of infectious laryngotracheitis virus. BMC Genomics 2011, 12:197.
3. Bankowski RA, Corstvet RE, Clark GT. Isolation of an unidentified agent from the respiratory tract of chickens. Science 1960, 132:292-293.
4. Crawshaw GJ, Boycott BR. Infectious laryngotracheitis in peafowl and pheasants. Avian Dis 1982, 26(2):397-401.
5. Bagust TJ, Jones RC, Guy JS. Avian infectious laryngotracheitis. Rev Sci Tech 2000, 19(2):483-492.
6. Knipe DM, Howley PM. Herpes Simplex Viruses. Fields Virology 2007, 2501-2061. 5.
7. Rodriguez-Avila A, Oldoni I, Riblet S, Garcia M. Replication and transmission of live attenuated infectious laryngotracheitis virus (ILTV) vaccines. Avian Dis 2007, 51(4):905-911.
8. Hughes CS, Williams RA, Gaskell RM, Jordan FT, Bradbury JM, Bennett M, Jones RC. Latency and reactivation of infectious laryngotracheitis vaccine virus. Arch Virol 1991, 121(1-4):213-218.
9. Guy JS, Barnes HJ, Smith L. Increased virulence of modified-live infectious laryngotracheitis vaccine virus following bird-to-bird passage. Avian Dis 1991, 35(2):348-355.
10. Meyer HM, Hopps HE, Parkman PD. Appraisal and reappraisal of viral vaccines. Adv Intern Med 1980, 25:533-560.
11. Guy JS, Barnes HJ, Munger LL, Rose L. Restriction endonuclease analysis of infectious laryngotracheitis viruses: comparison of modified-live vaccine viruses and North Carolina field isolates. Avian Dis 1989, 33(2):316-323.
12. Keeler CL, Hazel JW, Hastings JE, Rosenberger JK. Restriction endonuclease analysis of Delmarva field isolates of infectious laryngotracheitis virus. Avian Dis 1993, 37(2):418-426.
13. Oldoni I, Garcia M. Characterization of infectious laryngotracheitis virus isolates from the US by polymerase chain reaction and restriction fragment length polymorphism of multiple genome regions. Avian Pathol 2007, 36(2):167-176.
14. Khalid SS, Hamid S, Siddiqui AA, Qureshi A, Qureshi N. Gene profiling of early and advanced liver disease in chronic hepatitis C patients. Hepatol Int 2011, 5(3):782-788.
15. Satoh K, Shimizu T, Kondoh H, Hiraguri A, Sasaya T, Choi IR, Omura T, Kikuchi S. Relationship between symptoms and gene expression induced by the infection of three strains of Rice dwarf virus. PLoS One 2011, 6(3):e18094.
16. Mukherjee S, Vipat VC, Mishra AC, Pawar SD, Chakrabarti AK. Pandemic (H1N1) 2009 influenza virus induces weaker host immune responses in vitro: a possible mechanism of high transmissibility. Virol J 2011, 8:140.
17. Alberter B, Vogel B, Lengenfelder D, Full F, Ensser A. Genome-wide histone acetylation profiling of Herpesvirus saimiri in human T cells upon induction with a histone deacetylase inhibitor. J Virol 2011, 85(11):5456-5464.
18. de la Fuente C, Santiago F, Deng L, Eadie C, Zilberman I, Kehn K, Maddukuri A, Baylor S, Wu K, Lee CG, Pumfery A, Kashanchi F. Gene expression profile of HIV-1 Tat expressing cells: a close interplay between proliferative and differentiation signals. BMC Biochem 2002, 3:14.
19. Wu JQ, Dwyer DE, Dyer WB, Yang YH, Wang B, Saksena NK. Genome-wide analysis of primary CD4+ and CD8+ T cell transcriptomes shows evidence for a network of enriched pathways associated with HIV disease. Retrovirology 2011, 8:18.
20. Gupta N, Bhaskar AS, Lakshmana Rao PV. Transcriptional regulation and activation of the mitogen-activated protein kinase pathway after Japanese encephalitis virus infection in neuroblastoma cells. FEMS Immunol Med Microbiol 2011, 62(1):110-121.
21. Yang Y, Ye J, Yang X, Jiang R, Chen H, Cao S. Japanese encephalitis virus infection induces changes of mRNA profile of mouse spleen and brain. Virol J 2011, 8:80.
22. Crowley TM, Haring VR, Moore R. Chicken anemia virus: an understanding of the in-vitro host response over time. Viral Immunol 2011, 24(1):3-9.
23. Hertoghs KM, Moerland PD, van Stijn A, Remmerswaal EB, Yong SL, van de Berg PJ, van Ham SM, Baas F, ten Berge IJ, van Lier RA. Molecular profiling of cytomegalovirus-induced human CD8+ T cell differentiation. J Clin Invest 2010, 120(11):4077-4090.
24. Ye J, Gradoville L, Miller G. Cellular immediate-early gene expression occurs kinetically upstream of Epstein-Barr virus bzlf1 and brlf1 following cross-linking of the B cell antigen receptor in the Akata Burkitt lymphoma cell line. J Virol 2010, 84(23):12405-12418.
25. Lee JY, Song JJ, Wooming A, Li X, Zhou H, Bottje WG, Kong BW. Transcriptional profiling of host gene expression in chicken embryo lung cells infected with laryngotracheitis virus. BMC Genomics 2010, 11:445.
26. Ashrafi GH, Grinfeld E, Montague P, Forster T, Ross A, Ghazal P, Scott F, Breuer J, Goodwin R, Kennedy PG. Assessment of transcriptomal analysis of Varicella-Zoster-virus gene expression in patients with and without post-herpetic neuralgia. Virus Genes 2010, 41(2):192-201.
27. Szpara ML, Kobiler O, Enquist LW. A common neuronal response to alphaherpesvirus infection. J Neuroimmune Pharmacol 2010, 5(3):418-427.
28. Kano R, Konnai S, Onuma M, Ohashi K. Microarray analysis of host immune responses to Marek's disease virus infection in vaccinated chickens. J Vet Med Sci 2009, 71(5):603-610.
29. Clement C, Popp MP, Bloom DC, Schultz G, Liu L, Neumann DM, Bhattacharjee PS, Hill JM. Microarray analysis of host gene expression for comparison between naive and HSV-1 latent rabbit trigeminal ganglia. Mol Vis 2008, 14:1209-1221.
30. Bidzhieva B, Laassri M, Chumakov K. MAPREC assay for quantitation of mutants in a recombinant flavivirus vaccine strain using near-infrared fluorescent dyes. J Virol Methods 2011, 175(1):14-19.
31. Laassri M, Bidzhieva B, Speicher J, Pletnev AG, Chumakov K. Microarray hybridization for assessment of the genetic stability of chimeric West Nile/dengue 4 virus. J Med Virol 2011, 83(5):910-920.
32. Balas C, Kennel A, Deauvieau F, Sodoyer R, Arnaud-Barbe N, Lang J, Guy B. Different innate signatures induced in human monocyte-derived dendritic cells by wild-type dengue 3 virus, attenuated but reactogenic dengue 3 vaccine virus, or attenuated nonreactogenic dengue 1-4 vaccine virus strains. J Infect Dis 2011, 203(1):103-108.
33. Zahurak M, Parmigiani G, Yu W, Scharpf RB, Berman D, Schaeffer E, Shabbeer S, Cope L. Pre-processing Agilent microarray data. BMC Bioinforma 2007, 8:142.
34. Bitoun E, Micheloni A, Lamant L, Bonnart C, Tartaglia-Polcini A, Cobbold C, Al Saati T, Mariotti F, Mazereeuw-Hautier J, Boralevi F, Hohl D, Harper J, Bodemer C, D'Alessio M, Hovnanian A. LEKTI proteolytic processing in human primary keratinocytes, tissue distribution and defective expression in Netherton syndrome. Hum Mol Genet 2003, 12(19):2417-2430.
35. Streit M, Riccardi L, Velasco P, Brown LF, Hawighorst T, Bornstein P, Detmar M. Thrombospondin-2: a potent endogenous inhibitor of tumor growth and angiogenesis. Proc Natl Acad Sci USA 1999, 96(26):14888-14893.
36. Metodieva SN, Nikolova DN, Cherneva RV, Dimova II, Petrov DB, Toncheva DI. Expression analysis of angiogenesis-related genes in Bulgarian patients with early-stage non-small cell lung cancer. Tumori 2011, 97(1):86-94.
37. Miragliotta V, Raphael K, Ipina Z, Lussier JG, Theoret CL. Equine thrombospondin II and secreted protein acidic and cysteine-rich in a model of normal and pathological wound repair. Physiol Genomics 2009, 38(2):149-157.
38. Halestrap AP. What is the mitochondrial permeability transition pore?. J Mol Cell Cardiol 2009, 46(6):821-831.
39. Baines CP. The molecular composition of the mitochondrial permeability transition pore. J Mol Cell Cardiol 2009, 46(6):850-857.
40. Green DR, Reed JC. Mitochondria and apoptosis. Science 1998, 281(5381):1309-1312.
41. Zamzami N, Susin SA, Marchetti P, Hirsch T, Gomez-Monterrey I, Castedo M, Kroemer G. Mitochondrial control of nuclear apoptosis. J Exp Med 1996, 183(4):1533-1544.
42. Marchetti P, Castedo M, Susin SA, Zamzami N, Hirsch T, Macho A, Haeffner A, Hirsch F, Geuskens M, Kroemer G. Mitochondrial permeability transition is a central coordinating event of apoptosis. J Exp Med 1996, 184(3):1155-1160.
43. Marlovits TC, Abrahamsberg C, Blaas D. Very-low-density lipoprotein receptor fragment shed from HeLa cells inhibits human rhinovirus infection. J Virol 1998, 72(12):10246-10250.
44. Budhiraja S, Chugh A. Neuromedin U: physiology, pharmacology and therapeutic potential. Fundam Clin Pharmacol 2009, 23(2):149-157.
45. Novak CM. Neuromedin S and U. Endocrinology 2009, 150(7):2985-2987.
46. Moriyama M, Sato T, Inoue H, Fukuyama S, Teranishi H, Kangawa K, Kano T, Yoshimura A, Kojima M. The neuropeptide neuromedin U promotes inflammation by direct activation of mast cells. J Exp Med 2005, 202(2):217-224.
47. Moriyama M, Matsukawa A, Kudoh S, Takahashi T, Sato T, Kano T, Yoshimura A, Kojima M. The neuropeptide neuromedin U promotes IL-6 production from macrophages and endotoxin shock. Biochem Biophys Res Commun 2006, 341(4):1149-1154.
48. Howard L, Maciewicz RA, Blobel CP. Cloning and characterization of ADAM28: evidence for autocatalytic pro-domain removal and for cell surface localization of mature ADAM28. Biochem J 2000, 348(Pt 1):21-27.
49. Mochizuki S, Okada Y. ADAM28: involvement in cancer cell proliferation, invasion and metastasis. Seikagaku 2010, 82(10):940-949.
50. Ohtsuka T, Shiomi T, Shimoda M, Kodama T, Amour A, Murphy G, Ohuchi E, Kobayashi K, Okada Y. ADAM28 is overexpressed in human non-small cell lung carcinomas and correlates with cell proliferation and lymph node metastasis. Int J Cancer 2006, 118(2):263-273.
51. Mitsui Y, Mochizuki S, Kodama T, Shimoda M, Ohtsuka T, Shiomi T, Chijiiwa M, Ikeda T, Kitajima M, Okada Y. ADAM28 is overexpressed in human breast carcinomas: implications for carcinoma cell proliferation through cleavage of insulin-like growth factor binding protein-3. Cancer Res 2006, 66(20):9913-9920.
52. Zhao Z, Liu HC, Huang ZN. Effects of ADAM28 AS-ODN on proliferation, differentiation and apoptosis of HPDLSC. Shanghai Kou Qiang Yi Xue 2009, 18(5):524-531.
53. Mochizuki S, Shimoda M, Shiomi T, Fujii Y, Okada Y. ADAM28 is activated by MMP-7 (matrilysin-1) and cleaves insulin-like growth factor binding protein-3. Biochem Biophys Res Commun 2004, 315(1):79-84.
54. Ueno N, Ling N, Ying SY, Esch F, Shimasaki S, Guillemin R. Isolation and partial characterization of follistatin: a single-chain Mr 35,000 monomeric protein that inhibits the release of follicle-stimulating hormone. Proc Natl Acad Sci USA 1987, 84(23):8282-8286.
55. Thompson TB, Lerch TF, Cook RW, Woodruff TK, Jardetzky TS. The structure of the follistatin:activin complex reveals antagonism of both type I and type II receptor binding. Dev Cell 2005, 9(4):535-543.
56. Chen YG, Lui HM, Lin SL, Lee JM, Ying SY. Regulation of cell proliferation, apoptosis, and carcinogenesis by activin. Exp Biol Med (Maywood) 2002, 227(2):75-87.
57. Jones JO, Arvin AM. Viral and cellular gene transcription in fibroblasts infected with small plaque mutants of varicella-zoster virus. Antiviral Res 2005, 68(2):56-65.
58. May HG, Tittsler RP. Tracheolaryngotracheitis in poultry. J Am Vet Med Assoc 1925, 67:229-231.
59. Weigert J, Neumeier M, Schaffler A, Fleck M, Scholmerich J, Schutz C, Buechler C. The adiponectin paralog CORS-26 has anti-inflammatory properties and is produced by human monocytic cells. FEBS Lett 2005, 579(25):5565-5570.
60. Weigert C, Hennige AM, Brodbeck K, Haring HU, Schleicher ED. Interleukin-6 acts as insulin sensitizer on glycogen synthesis in human skeletal muscle cells by phosphorylation of Ser473 of Akt. Am J Physiol Endocrinol Metab 2005, 289(2):E251-257.
61. Wolfing B, Buechler C, Weigert J, Neumeier M, Aslanidis C, Schoelmerich J, Schaffler A. Effects of the new C1q/TNF-related protein (CTRP-3) "cartonectin" on the adipocytic secretion of adipokines. Obesity (Silver Spring) 2008, 16(7):1481-1486.
62. Botto S, Streblow DN, DeFilippis V, White L, Kreklywich CN, Smith PP, Caposio P. IL-6 in human cytomegalovirus secretome promotes angiogenesis and survival of endothelial cells through the stimulation of survivin. Blood 2011, 117(1):352-361.
63. Kong BW, Song JJ, Lee JY, Hargis BM, Wing T, Lassiter K, Bottje W. Gene expression in breast muscle associated with feed efficiency in a single male broiler line using a chicken 44 K oligo microarray. I Top differentially expressed genes Poult Sci 2011, 90(11):2535-2547.
64. Zhang ZQ, Song YL, Chen ZH, Shen Y, Bai CX. Deletion of Aquaporin 5 Aggravates Acute Lung Injury Induced by Pseudomonas aeruginosa. J Trauma 2011, 71(5):1305-1311.
65. Shankardas J, Patil RV, Vishwanatha JK. Effect of down-regulation of aquaporins in human corneal endothelial and epithelial cell lines. Mol Vis 2010, 16:1538-1548.
66. Towne JE, Harrod KS, Krane CM, Menon AG. Decreased expression of aquaporin (AQP)1 and AQP5 in mouse lung after acute viral infection. Am J Respir Cell Mol Biol 2000, 22(1):34-44.
67. Jensen RT, Wank SA, Rowley WH, Sato S, Gardner JD. Interaction of CCK with pancreatic acinar cells. Trends Pharmacol Sci 1989, 10(10):418-423.
68. Gukovskaya AS, Gukovsky I, Jung Y, Mouria M, Pandol SJ. Cholecystokinin induces caspase activation and mitochondrial dysfunction in pancreatic acinar cells. Roles in cell injury processes of pancreatitis. J Biol Chem 2002, 277(25):22595-22604.
69. Vlahakis NE, Young BA, Atakilit A, Sheppard D. The lymphangiogenic vascular endothelial growth factors VEGF-C and -D are ligands for the integrin alpha9beta1. J Biol Chem 2005, 280(6):4544-4552.
70. Wen L, Zhuang L, Luo X, Wei P. TL1A-induced NF-kappaB activation and c-IAP2 production prevent DR3-mediated apoptosis in TF-1 cells. J Biol Chem 2003, 278(40):39251-39258.
71. Refojo D, Echenique C, Muller MB, Reul JM, Deussing JM, Wurst W, Sillaber I, Paez-Pereda M, Holsboer F, Arzt E. Corticotropin-releasing hormone activates ERK1/2 MAPK in specific brain areas. Proc Natl Acad Sci USA 2005, 102(17):6183-6188.
72. Campbell JS, Hughes SD, Gilbertson DG, Palmer TE, Holdren MS, Haran AC, Odell MM, Bauer RL, Ren HP, Haugen HS, Yeh MM, Fausto N. Platelet-derived growth factor C induces liver fibrosis, steatosis, and hepatocellular carcinoma. Proc Natl Acad Sci USA 2005, 102(9):3389-3394.
73. Sato Y, Takahashi M, Shibukawa Y, Jain SK, Hamaoka R, Miyagawa J, Yaginuma Y, Honke K, Ishikawa M, Taniguchi N. Overexpression of N-acetylglucosaminyltransferase III enhances the epidermal growth factor-induced phosphorylation of ERK in HeLaS3 cells by up-regulation of the internalization rate of the receptors. J Biol Chem 2001, 276(15):11956-11962.
74. Sugaya N, Habuchi H, Nagai N, Ashikari-Hada S, Kimata K. 6-O-sulfation of heparan sulfate differentially regulates various fibroblast growth factor-dependent signalings in culture. J Biol Chem 2008, 283(16):10366-10376.
75. Artero-Castro A, Callejas FB, Castellvi J, Kondoh H, Carnero A, Fernandez-Marcos PJ, Serrano M, Ramon Y, Cajal S, Lleonart ME. Cold-inducible RNA-binding protein bypasses replicative senescence in primary cells through extracellular signal-regulated kinase 1 and 2 activation. Mol Cell Biol 2009, 29(7):1855-1868.
76. Kuhn H, Borchert A. Regulation of enzymatic lipid peroxidation: the interplay of peroxidizing and peroxide reducing enzymes. Free Radic Biol Med 2002, 33(2):154-172.
77. Blitz IL, Cho KW. Finding partners: how BMPs select their targets. Dev Dyn 2009, 238(6):1321-1331.
78. Blanco Calvo M, Bolos Fernandez V, Medina Villaamil V, Aparicio Gallego G, Diaz Prado S, Grande Pulido E. Biology of BMP signalling and cancer. Clin Transl Oncol 2009, 11(3):126-137.
79. Yin Q, Wang X, Fewell C, Cameron J, Zhu H, Baddoo M, Lin Z, Flemington EK. MicroRNA miR-155 inhibits bone morphogenetic protein (BMP) signaling and BMP-mediated Epstein-Barr virus reactivation. J Virol 2010, 84(13):6318-6327.
80. Cotter EJ, Ip HS, Powderly WG, Doran PP. Mechanism of HIV protein induced modulation of mesenchymal stem cell osteogenic differentiation. BMC Musculoskelet Disord 2008, 9:33.
81. Du M, Butchi NB, Woods T, Morgan TW, Peterson KE. Neuropeptide Y has a protective role during murine retrovirus-induced neurological disease. J Virol 2010, 84(21):11076-11088.
82. Garry EM, Delaney A, Anderson HA, Sirinathsinghji EC, Clapp RH, Martin WJ, Kinchington PR, Krah DL, Abbadie C, Fleetwood-Walker SM. Varicella zoster virus induces neuropathic changes in rat dorsal root ganglia and behavioral reflex sensitisation that is attenuated by gabapentin or sodium channel blocking drugs. Pain 2005, 118(1-2):97-111.
83. Ng LF, Hibberd ML, Ooi EE, Tang KF, Neo SY, Tan J, Murthy KR, Vega VB, Chia JM, Liu ET, Ren EC. A human in vitro model system for investigating genome-wide host responses to SARS coronavirus infection. BMC Infect Dis 2004, 4:34.
84. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25(4):402-408.
85. Fisher RA. On the interpretation of X2 from contingency tables, and the calculation of P. J R Stat Soc 1922, 85(1):87-94.
86. Mori R, Xiong S, Wang Q, Tarabolous C, Shimada H, Panteris E, Danenberg KD, Danenberg PV, Pinski JK. Gene profiling and pathway analysis of neuroendocrine transdifferentiated prostate cancer cells. Prostate 2009, 69(1):12-23.
87. Calvano SE, Xiao W, Richards DR, Felciano RM, Baker HV, Cho RJ, Chen RO, Brownstein BH, Cobb JP, Tschoeke SK, Miller-Graziano C, Moldawer LL, Mindrinos MN, Davis RW, Tompkins RG, Lowry SF. Inflamm and Host Response to Injury Large Scale Collab. Res. Program: A network-based analysis of systemic inflammation in humans. Nature 2005, 437(7061):1032-1037.